Press release
Particulate Respirators Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024
Particulate respirators are medical devices, which helps to protect one from harmful particles present in the air or dust or harmful fumes. Such harmful dust usually spread through severe acute respiratory syndrome (SARS). SARS is a respiratory syndrome commonly spread among symptomatic individuals, by person-to-person contact, or when the person sneezes or coughs, thereby infecting the nearby surfaces or through airborne transmission. Being a communicable disease, healthcare professionals and medical transport workers are at high risk to such disease as they frequently come in contact with patients suffering from SARS. Hence, Center for Disease Control and Prevention (CDC) has issued interim infection control recommendations for those high risky healthcare centers and facilities. Particulate respirators have proved to be excellent personal protector equipment in order to reduce the risk of inhaling harmful airborne particles. Particulate respirators which has the capability of filtering out 95% of airborne particles are given a 95 rating according to CDC. Likewise, respirators with 99% capability of filtering particles are given a 99 rating and so on.
Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/59
Government initiatives are helping spread awareness among SARS affected victims and helps in fostering market growth
Increasing prevalence of SARS is one of the major drivers impacting the particulate respirators market growth. Moreover, low cost of the product, increasing R&D activities and government initiatives undertaken in order to secure the healthcare professionals from such airborne transmission are some of the factors fueling the demand for particulate respirators. CDC is working with federal agencies, healthcare organizations and local health departments in order to spread awareness among healthcare workers for rapid recognition of person-to-person transmission of SARS. However, lack of proper awareness among people pertaining to the various types of particulate respirators available is hindering the market growth
Disposable respirators are less costly and easy to discard if damaged
On the basis of product, particulate respirators market is segmented into disposable or filtering facepiece respirators, reusable or elastomeric respirators and powered air-purifying respirators. Disposable respirators are for single-use as it gets damaged physically due to excessive resistance and sorbent exhaustion. Reusable respirators are cleaned and reused. However, the filter cartridges are disposed when they become unsuitable for use. Powered air-purifying respirators are usually attached with a battery powered blower which filters the harmful air.
Request for Complete TOC before buying this exclusive Report by CMI @ https://www.coherentmarketinsights.com/ongoing-insight/toc/59
Based on design, particulate respirators are of two types, half face respirators and full face respirators. Particulate respirators are used in hospital settings and also for military, laboratory and other purposes. On the basis of geography, the market is divided into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Greater awareness levels in North America is enhancing the market growth
North America is one of the high revenue generating market for particulate respirators owing to their growing awareness levels regarding the usage of particulate respirators and increasing R&D activities in this region. Asia Pacific is considered as a lucrative market for growing opportunities of particulate respirators primarily due to the rising prevalence of respiratory disorders in countries like India. The major players are expected to find huge growth opportunities in such countries owing to the rising airborne transmitted diseases.
Get 10% Discount for First Time Buyers @ https://www.coherentmarketinsights.com/insight/request-discount/59
3M is one of the leading players of the market based on the performance and sales
Some of the key players for particulate respirators market include 3M Company, The Gerson Company, Drägerwerk AG & Co. KGaA, Honeywell International Inc., MOLDEX and Northern Safety Co., Inc. among others. New product launch is one of the key initiatives undertaken by these companies. For instance, in 2015, 3M launched organic vapor respirator cartridges, which has 3M Service Life Indicator technology that helps to direct the user for an appropriate time to change the cartridges.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Particulate Respirators Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024 here
News-ID: 467232 • Views: …
More Releases for SARS
Two potent novel antiviral drugs for SARS-CoV-2
The global Antiviral Drugs Market is at the forefront of infectious disease management, playing a critical role in preventing and treating viral infections ranging from influenza and HIV to hepatitis and emerging pandemics. With the continuous threat of viral outbreaks and the evolution of drug-resistant strains, innovation in antiviral therapies has never been more important. Advances in molecular virology, combination therapies, and next-generation antivirals are reshaping treatment strategies. By 2034,…
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Market Outlook 20 …
Introduction
Severe Acute Respiratory Syndrome (SARS) is a viral respiratory illness caused by a coronavirus (SARS-CoV). The outbreak of SARS in 2002-2003 marked the world's first encounter with a highly transmissible coronavirus capable of causing severe morbidity and mortality. While SARS was contained, subsequent coronavirus outbreaks, including Middle East Respiratory Syndrome (MERS) and COVID-19 (SARS-CoV-2), highlighted the urgent global need for rapid diagnostics, vaccines, and antiviral therapeutics targeting coronaviruses.
Today, the SARS…
Existing Drugs May Inhibit SARS-CoV-2 Virus
The COVID-19 pandemic has caused more than 600,000 deaths in the United States since the start of 2020 and more than 4 million globally. The search for effective treatments against the disease are ongoing, and one hurdle is that SARS-CoV-2, the virus that causes COVID-19, has a number of tricks up its molecular sleeve when it comes to infecting people.
In a recent study published in Nature Communications Biology, researchers from…
trenzyme GmbH offers recombinant SARS-CoV-2 S1 protein to support Coronavirus re …
The 2019 novel coronavirus SARS-CoV-2 has caused an outbreak of the respiratory illness COVID-19 that started in China and has now spread throughout the world. Meanwhile, the spread of coronavirus has a strong impact on our daily life and the World Health Organization (WHO) has declared a global health emergency to gather resources to fight against this threat.
To support SARS-CoV-2 research, trenzyme offers off-the-shelf recombinant protein of the receptor…
Severe Acute Respiratory Syndrome (SARS) Coronavirus infections : Is there any l …
Worldwide Market Reports adds "Severe Acute Respiratory Syndrome (Sars) Coronavirus Infection Market 2020 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2027" reports to its database.
This report provides in depth study of "Severe Acute Respiratory Syndrome (Sars) Coronavirus Infection Market" using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organisation. The Severe Acute Respiratory Syndrome (Sars) Coronavirus Infection Market report also provides an in-depth survey of…
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017, provides an overview of the Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) pipeline landscape.
Severe acute respiratory syndrome (SARS) is a serious, potentially…
